Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations

被引:157
作者
Woolf, Steven [3 ,4 ]
Schuenemann, Holger J. [5 ,6 ]
Eccles, Martin P. [7 ]
Grimshaw, Jeremy M. [8 ,9 ]
Shekelle, Paul [1 ,2 ]
机构
[1] RAND Corp, Santa Monica, CA 90407 USA
[2] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA
[3] Virginia Commonwealth Univ, Dept Family Med, Richmond, VA USA
[4] Virginia Commonwealth Univ, Ctr Human Needs, Richmond, VA USA
[5] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
[6] McMaster Univ, Dept Med, Hamilton, ON, Canada
[7] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England
[8] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada
[9] Univ Ottawa, Dept Med, Ottawa, ON, Canada
关键词
SHARED DECISION-MAKING; HEALTH-CARE CONSUMERS; QUALITY; STRENGTH; MEDICINE; CONSENSUS; NUMBERS; SYMBOLS; BODE; ADO;
D O I
10.1186/1748-5908-7-61
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Clinical practice guidelines are one of the foundations of efforts to improve healthcare. In 1999, we authored a paper about methods to develop guidelines. Since it was published, the methods of guideline development have progressed both in terms of methods and necessary procedures and the context for guideline development has changed with the emergence of guideline clearinghouses and large scale guideline production organisations (such as the UK National Institute for Health and Clinical Excellence). It therefore seems timely to, in a series of three articles, update and extend our earlier paper. In this second paper, we discuss issues of identifying and synthesizing evidence: deciding what type of evidence and outcomes to include in guidelines; integrating values into a guideline; incorporating economic considerations; synthesis, grading, and presentation of evidence; and moving from evidence to recommendations.
引用
收藏
页数:12
相关论文
共 64 条
[1]   Symbols were superior to numbers for presenting strength of recommendations to health care consumers: a randomized trial [J].
Akl, Elie A. ;
Maroun, Nancy ;
Guyatt, Gordon ;
Oxman, Andrew D. ;
Alonso-Coello, Pablo ;
Vist, Gunn E. ;
Devereaux, P. J. ;
Montori, Victor M. ;
Schunemann, Holger J. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2007, 60 (12) :1298-1305
[2]  
[Anonymous], GERMAN J EVID QUAL H
[3]  
[Anonymous], 2002, SYSTEMS RATE STRENGT
[4]  
[Anonymous], HLTH RES POLICY SYST
[5]  
[Anonymous], HLTH RES POLICY SYST
[6]  
[Anonymous], 1980, Clinical Decision Analysis
[7]  
[Anonymous], AHCPR PUBLICATION
[8]  
Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
[9]  
BATTISTA R N, 1988, American Journal of Preventive Medicine, V4, P53
[10]  
Battista RN, 1988, AM J PREV MED, V4, P68